Neuroscience and Behavioral Physiology

, Volume 30, Issue 1, pp 37–43 | Cite as

The differentiation of dopaminergic neurons in situ, in vivo, and in transplants

  • M. V. Ugryumov
Article

Abstract

This article summarizes results obtained from studies on the differentiation of dopaminergic neurons in animal hypothalamus and human substantia nigra in situ, in vitro, and in transplants, as well as the role of the microenvironment in regulating this process. Four stages were identified in the differentiation of dopaminergic neurons from rat hypothalamus: a) formation of neurons from neuroepithelial precursor cells, b) expression of specific synthetic products (enzymes and dopamine itself) and mechanisms for transmembrane dopamine transport (reuptake and secretion in response to membrane depolarization), c) formation of permanent and transient efferent connections, and d) formation of afferent innervation and synaptogenesis. Along with dopaminergic neurons, rat fetuses contained neurons expressing only one of the dopamine-synthesizing enzymes and probably taking part in in situ dopamine synthesis. Differentiation of dopaminergic neurons was sexually dimorphic in terms of the dynamics of neuron formation and expression of enzymes involved in dopamine synthesis. A neurotransplantation model showed that humoral factors of placental and maternal origin had no significant effect on the differentiation of the dopaminergic neurons of the hypothalamus. As regards the dopaminergic neurons of the substantia nigra, expression of their specific phenotype in human fetuses started with the synthesis of tyrosine hydroxylase and co-maturation of the specific dopamine reuptake mechanism during the sixth week of development. During the next four weeks, specific uptake increased, and this appears to be a measure of the number of neurons and the growth of their processes. These data provide the basis for regarding the period from week 6 to week 10 as optimal for transplantation of dopaminergic neurons into the striatum of patients with Parkinson's disease. Suspensions of fetal substantia nigra cells enriched with dopaminergic neurons were introduced stereotaxically into a patient's striatum through a cannula. Positron emission tomography studies showed that the transplanted neurons survived within the host brain, underwent differentiation, and started to synthesize dopamine. The results of clinical assessment performed in parallel with these studies suggested that the transplanted dopaminergic neurons were involved in regulating striatal target neurons.

Key Words

development neuron dopamine sexual dimorphism neurotransplantation rat humans 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    M. V. Ugryumov, S. O. Fetisov, A. P. Popov, E. S. Efuni, N. G. Titova, J. Thibault, and M. Krieger, “Development of transplants of embryonic mediobasal hypothalamus in the third ventricle of the brains of adult rats,”Izv. Ros. Akad. Nauk Ser. Biol.,3, 340–351 (1994).Google Scholar
  2. 2.
    M. V. Ugryumov, V. A. Shabalov, N. V. Fedorov, A. P. Popov, V. N. Shtok, E. I. Sotnikova, A. G. Melikyan, T. A. Gatina S. O. Fetisov, N. A. Arkhipova, S. B. Buklina, and V. S. Lutsenko, “The use of neurotransplantation in the treatment of Parkinson's disease,”Vestn. Ros. Akad. Med. Nauk,8, 40–51 (1996).Google Scholar
  3. 3.
    S. O. Fetisov, A. P. Popov, E. S. Efuni, J. Thibault, M. Krieger, and M. V. Ugryumov, “Phenotype expression in dopaminergic neurons in the arcuate nucleus of the hypothalamus in transplants,”Dokl. Ros. Akad. Nauk,334, 124–126 (1994).Google Scholar
  4. 4.
    I. S. Balan, M. V. Ugrumov, N. A. Borisova, A. Calas, C. Pilgrim, I. Reisrt, and J. Thibault, “Birthdates of the tyrosine hydroxylase immunoreactive neurons in the hypothalamus of male and female rats,”Neuroendocrinology,64, 405–411 (1996).PubMedGoogle Scholar
  5. 5.
    I. S. Balan, M. V. Ugrumov, A. Calas, P. Mailly, M. Krieger, and J. Thibault,” Tyrosine hydroxylase- and/or aromatic L-amino decarboxylase-expressing neurons in the mediobasal hypothalamus of perinatal rats: differentiation and sexual dimorphism,”J. Comp. Neurol. (in press)Google Scholar
  6. 6.
    M. J. Baum, P. J. A. Wouterson, and A. K. Slob, “Sex difference in whole-body androgen content in rats on fetal days 18 and 19 without evidence that androgen passes from males to females,”Biol. Reprod.,44, 747–751 (1991).PubMedCrossRefGoogle Scholar
  7. 7.
    M. Beltramo, A. Calas, N. Chernigovskaya, N. Borisova, O. Polenova, Y. Tillet, J. Thibault, and M. Ugrumov, “Postnatal development of the suprachiasmatic nucleus in the rat. Morphofunctional characteristics and time course of tyrosine hydroxylase immunopositive fibers,”Neuroscience,63, 603–610 (1994).PubMedCrossRefGoogle Scholar
  8. 8.
    A. Björklund and O. Lindvall, “Dopamine-containing systems of the CNS,” in:Handbook of Chemical Neuroanatomy, Part I:Classical Neurotransmitters in the CNS, A. Björklund and T. Hökfelt (Eds.) Elsevier, Amsterdam, New York Oxford (1984), Vol. 2, pp. 55–122.Google Scholar
  9. 9.
    N. A. Borisova, A. Y. Proshlyakova, and M. V. Ugrumov, “Ontogenesis of the hypothalamic catecholaminergic system in rats. Synthesis, uptake and release of catecholamines,”Neuroscience,43, 223–229 (1991).PubMedCrossRefGoogle Scholar
  10. 10.
    P. Brundin, A. Björklund, and O. Lindvall, “Practical aspects of the use of human fetal brain tissue for intracerebral grafting,”Prog. Brain Res.,42, 707–714 (1990).CrossRefGoogle Scholar
  11. 11.
    T. Hökfelt, R. Martensson, A. Björklund, S. Kleinau, and M. Goldstein, “Distributional maps of tyrosine hydroxylase-immunoreactive neurons in the rat brain,” in:Handbook of Chemical Neuroanatomy, Part I:Classisical Neurotransmitters in the CNS, A. Björklund and T. Hökfelt (Eds.), Elsevier, Amsterdam, New York, Oxford (1984), Vol. 2, pp. 277–379.Google Scholar
  12. 12.
    C. B. Jaeger, “Aromatic L-amino acid decarboxylase in the rat brain: immunocytochemical localization during neonatal development,”Neuroscience,18, 121–150 (1986).PubMedCrossRefGoogle Scholar
  13. 13.
    O. Lindvall, “Prospects of transplantation in human neurodegenerative diseases,”Trends Neurosci. 14, 376–384 (1991).PubMedCrossRefGoogle Scholar
  14. 14.
    B. Meister, T. Hökfelt, H. W. M. Steinbusch, G. Skagerberg, O. Lindvall, M. Geffard, T. H. Goh, A. C. Cuello, and M. Goldstein, “Do tyrosine hydroxylase-immunoreactive neurons in the ventrolateral arcuate nucleus produce dopamine or only L-dopa?,”J. Chem. Neuroanat.,1, 59–64 (1988).PubMedGoogle Scholar
  15. 15.
    V. Melnikova, M. Orosco, C. Calas, A. Sapronova, R. Gainetdinov, N. Delhaye-Bouchaud, S. Nicolaidis, K. Rayevsky, and M. Ugrumov, “Dopamine turnover in the mediobasal hypothalamus in rat fetuses: in vivo, ex vivo, and in cell culture study,”Neuroscience (in press).Google Scholar
  16. 16.
    V. Melnikova, M. Orosco, C. Rouch, A. Calas, S. Nicolaidis, E. Proshlyakova, A. Sapronova, and M. Ugrumov, “Prolactin secretion and its dopamine inhibitory control in rat fetuses,”Eur. J. Endocrinol. (in press).Google Scholar
  17. 17.
    M. V. Ugrumov, “Developing hypothalamus in differentiation of neurosecretory neurons and in establishment of pathways for neurohormone transport,”Int. Rev. Cytol.,129, 207–267 (1991).PubMedCrossRefGoogle Scholar
  18. 18.
    M. V. Ugrumov, “Hypothalamic catecholaminergic systems in ontogenesis: development and functional significance,” in:Phylogeny and Development of Catecholamine Systems in the CNS of Vertebrates, W. J. A. Smeets and A. Reiner (Eds.), Cambridge University Press, Cambridge (1994), pp. 435–452.Google Scholar
  19. 19.
    M. V. Ugrumov, “Hypothalamic monoaminergic systems in ontogenesis: development and functional significance,”Int. J. Dev. Biol.,41, 809–816 (1997).PubMedGoogle Scholar
  20. 20.
    M. V. Ugrumov, T. Taxi, A. Tixier-Vidal, J. Thibault, and M. S. Mitskevich, “Ontogenesis of tyrosine hydroxylase-immunopositive structures in the rat hypothalamus. An atlas of neuronal cell bodies,”Neuroscience,29, 135–156 (1989).PubMedCrossRefGoogle Scholar
  21. 21.
    M. V. Ugrumov, A. Tixier-Vidal, J. Taxi, J. Thibault, and M. S. Mitskevich, “Ontogenesis of tyrosine hydroxylase-immunopositive structures in the rat hypothalamus. Fiber pathways and terminal fields,”Neuroscience,29, 157–166 (1989).PubMedCrossRefGoogle Scholar
  22. 22.
    M. V. Ugrumov, A. P. Popov, S. V. Vladimirov, S. Kasmambetova, and J. Thibault, “Development of the suprachiasmatic nucleus during ontogenesis. Tyrosine hydroxylase immunopositive cell bodies and fibers,”Neuroscience,58, 151–160 (1994).PubMedCrossRefGoogle Scholar
  23. 23.
    M. V. Ugrumov, E. V. Proshlyakova, A. Y. Sapronova, and A. P. Popov, “Development of the mesencephalic and diencephalic catecholaminergic systems in human fetuses: uptake and release of catecholamines in vitro,”Neurosci. Lett. 212, 29–32 (1996).PubMedCrossRefGoogle Scholar
  24. 24.
    M. V. Ugrumov, N. Leenders, V. A. Shablov, N. V. Fedorova, L. A. Zakharova, I. G. Makarenko, and A. P. Popov, “Combined neurological, PET and immunological examination of PD patients following neurotransplantation” (in press).Google Scholar
  25. 25.
    N. Zecevic and C. Verney, “Development of the catecholaminergic neurons in human embryos and fetuses, with special emphasis on the innervation of the cerebral cortex,J. Comp. Neurol. 351, 509–535 (1995).PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic/Plenum Publishers 2000

Authors and Affiliations

  • M. V. Ugryumov
    • 1
    • 2
  1. 1.N. K. Kol'tsov Institute of Developmental BiologyRussian Academy of SciencesMoscowRussia
  2. 2.P. K. Anokhin Institute of Normal PhysiologyRussian Academy of Medical SciencesMoscowRussia

Personalised recommendations